VolitionRx Limited (NYSE American: VNRX) said it fully prepaid in cash the outstanding balance of its $7.5 million senior secured convertible promissory note dated May 20, 2025, issued to Lind Global Asset Management XII LLC. The repayment satisfies all obligations under the note more than eight months before its scheduled May 20, 2027 maturity. A separate senior secured convertible promissory note dated Jan. 7, 2026, originally valued at $2.4 million and also issued to Lind, remains outstanding at $2,041,667. Chief Executive Officer Cameron Reynolds said the cash repayment prevents further potential dilution associated with the retired note and that reducing debt and expenses remains a priority. Volition is developing blood tests focused on earlier disease detection and monitoring, including for some cancers and diseases associated with NETosis such as sepsis.